Stage III Bladder Cancer AJCC v8 Not Yet Recruiting Phase 2 Trials for Vinblastine (DB00570)

IndicationStatusPhase
DBCOND0109731 (Stage III Bladder Cancer AJCC v8)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04216290A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, the INSPIRE StudyTreatment